85 related articles for article (PubMed ID: 7221971)
1. Clinico-pharmacological examinations with Ovidon.
Farkas M
Ther Hung; 1980; 28(3):118-28. PubMed ID: 7221971
[TBL] [Abstract][Full Text] [Related]
2. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
Farkas M
Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
[TBL] [Abstract][Full Text] [Related]
3. Experience with hormonal contraceptives.
Kulakov VI
Acta Med Hung; 1986; 43(2):93-6. PubMed ID: 3588163
[TBL] [Abstract][Full Text] [Related]
4. Clinical observations with Rigevidon.
Bálint S
Ther Hung; 1980; 28(2):75-8. PubMed ID: 7466718
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
6. Comparative data on the liver- and lipid metabolism influencing effects of Anteovin.
Pilishegyi J
Ther Hung; 1987; 35(2):71-6. PubMed ID: 3438865
[TBL] [Abstract][Full Text] [Related]
7. [Clinical trial of the combined contraceptive preparation, Ovidon].
Nalbanski B
Akush Ginekol (Sofiia); 1979; 18(5):388-91. PubMed ID: 391067
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
9. [The clinico-pharmacological characteristics of anteovin].
Nikanorova SA; Kononova ES; Korkhov VV; Potin VV; Svechnikova FA; Boĭkova VV
Farmakol Toksikol; 1991; 54(1):30-1. PubMed ID: 1860494
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pharmacological examination of Postinor (0.75 mg d-norgestrel).
Farkas M; Apró G; Sas M
Ther Hung; 1981; 29(1):22-30. PubMed ID: 7188237
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
12. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
Nilsson CG; Lähteenmäki P
Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
[TBL] [Abstract][Full Text] [Related]
13. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
14. Clinicopharmacological examination of Anteovin.
Farkas M; Szigethy A; Sas M
Ther Hung; 1987; 35(1):14-8. PubMed ID: 3438859
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral contraceptives on vitamin B6 nutriture of young women.
Vir SC; Love AH
Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712
[TBL] [Abstract][Full Text] [Related]
16. Early effect of a low dose (30 micrograms) ethinyl estradiol-containing Triphasil on vitamin B6 status. A follow-up study on six menstrual cycles.
Massé PG; van den Berg H; Duguay C; Beaulieu G; Simard JM
Int J Vitam Nutr Res; 1996; 66(1):46-54. PubMed ID: 8698546
[TBL] [Abstract][Full Text] [Related]
17. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
18. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
Erodogan M; Inal A; Ozgu M; Beksac MS; Ergurbuz I
Acta Reprod Turc; 1980 Jan; 1(3):85-91. PubMed ID: 12262090
[TBL] [Abstract][Full Text] [Related]
20. [Effects of hormonal contraceptives on menstrual and reproductive function of women].
Dubnitskaia LV; Sotnikova EI
Akush Ginekol (Mosk); 1990 Apr; (4):57-60. PubMed ID: 1696071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
